Prescribing in COVID-19 patients: Should we take into account inflammation?
Details
Request a copy Under indefinite embargo.UNIL restricted access
State: Public
Version: Final published version
License: Not specified
Serval ID
serval:BIB_828321D63244
Type
Article: article from journal or magazin.
Publication sub-type
Editorial
Collection
Publications
Institution
Title
Prescribing in COVID-19 patients: Should we take into account inflammation?
Journal
British journal of clinical pharmacology
ISSN
1365-2125 (Electronic)
ISSN-L
0306-5251
Publication state
Published
Issued date
03/2021
Peer-reviewed
Oui
Volume
87
Number
3
Pages
719-721
Language
english
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't ; Review
Publication Status: ppublish
Publication Status: ppublish
Keywords
Anti-Inflammatory Agents/therapeutic use, Antiviral Agents/therapeutic use, COVID-19/complications, Drug Prescriptions, Drug Therapy, Combination, Humans, Inflammation/drug therapy, Inflammation/etiology, COVID-19 Drug Treatment, COVID-19, drug-drug interactions, inflammation, inhibition drug metabolism
Pubmed
Web of science
Open Access
Yes
Create date
25/08/2023 5:17
Last modification date
19/09/2024 15:13
Usage data
